Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
XE ›
XETHAZAT
Trademark search for:
XETHAZAT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-08-12 — Application filed
2014-08-15 — Application filed
2014-08-15 — Teas amendment entered before attorney assigned
2014-08-15 — Teas voluntary amendment received
2014-08-21 — Application filed
2014-09-08 — Teas voluntary amendment received
2014-09-11 — Assigned to lie
2014-09-18 — Preliminary/voluntary amendment - entered
2014-11-01 — Approved for pub - principal register
2014-11-01 — Assigned to examiner
2014-11-04 — Law office publication review completed
2014-11-19 — Notification of notice of publication e-mailed
2014-12-09 — Published for opposition
2014-12-09 — Official gazette publication confirmation e-mailed
2014-12-19 — Teas delete 1(b) basis received
2014-12-23 — Application abandoned
2014-12-23 — Application abandoned
2015-01-07 — Teas request for reinstatement
2015-02-20 — Assigned to petition staff
2015-02-23 — Application abandoned
2015-02-27 — Notice of reinstatement mailed
2015-03-31 — Registered-principal register
2016-03-31 — Teas change of correspondence received
2020-03-31 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-12-03 — Cancelled sec. 8 (6-yr)
2021-12-03 — Final status recorded
Owner Information
SANOFI
Paris FR
SANOFI
Paris FR
SANOFI
Paris FR
Correspondent
MIDGE M. HYMAN COWAN, LIEBOWITZ & LATMAN, P.C. 114 West 47th Street NEW YORK, NY 10036-1525 UNITED STATES
Filing Details
Filing Date:
2014-08-12
Status Date:
2021-12-03
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.